Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Influenza mRNA Vaccines
April 27, 2023
Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Menu

Norbert Pardi
Research Assistant Professor of Medicine at University of Pennsylvania, USA
Speaker

Profile

Dr. Norbert Pardi holds a Ph.D. in biochemistry and genetics. He has been working at the University of Pennsylvania since 2011 and currently holds an Assistant Professor position at the Department of Microbiology of the Perelman School of Medicine. His research interest is the development of mRNA-based therapeutics with particular focus on new generation vaccines. He explored the development of a novel vaccine platform using nucleoside-modified mRNA in lipid nanoparticles (LNPs) and used it to generate highly effective vaccines targeting various pathogens. Dr. Pardi is a pioneer of the nucleoside-modified mRNA vaccine technology and published milestone papers in the field.

Agenda Sessions

  • Broadly Protective Influenza Vaccines using Nucleoside-Modified mRNA

    , 11:05am
    View Session

At this event

Prev
Next
Martin Friede
Coordinator, Initiative for Vaccine Research (IVR)
World Health Organisation, Switzerland

See Norbert at Influenza mRNA Vaccines